On February 13, 2013, the Federal Trade Commission (“FTC”) released an advisory opinion approving Norman PHO’s proposed “clinically integrated” network after a review process that took roughly a year and nine months (“Norman PHO Advisory Opinion”). This is the FTC’s latest advisory opinion discussing the merits of clinical integration programs from an antitrust perspective and…Read More
FTC Approves Norman PHO Clinical Integration Program
Posted on February 20, 2013 in Health Law News
Published by: Hall Render